One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2018-99-111163
Copy DOI Journal: Blood |  Publication Date: Nov 29, 2018 |
 Citations: 2 |
Affiliation: Universitair Ziekenhuis Brussel, Ghent University Hospital, The Christie NHS Foundation Trust, University of Manchester, University College Hospital, University College London, St James's University Hospital, Wayne State University, Karmanos Cancer Institute, Pharmacyclics (United States), AbbVie (United States), University of California, Los Angeles, Cornell University, The University of Texas MD Anderson Cancer Center, Universitair Ziekenhuis Leuven, King's College Hospital NHS Foundation Trust, Cliniques Universitaires Saint-Luc, Hackensack University Medical Center, Cancer Research UK, Vanderbilt University, Levine Cancer Institute, Carolinas Healthcare SystemThe iR2 Regimen(Ibrutinib, Lenalidomide, and Rituximab) Is Active with a Manageable Safety Profile in Patients with Relapsed/Refractory Non-Germinal Center-like Diffuse Large B-Cell Lymphoma
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
